R-Biopharm is part of an international research consortium of 14 partners with a strong focus on industrialization. The research project´s objective is the development of a pilot line for paper based electrochemical test strips dedicated to quantitative biosensing in liquids. By means of lateral flow tests the strips will be able to perform the discrimination between bacterial and viral infections – and the result will be legible with smartphone reader. With the help of faster and more accurate diagnosis in the future the prescription of antibiotics should be reduced. IMPETUS will pave the way towards the real world application of paper-based quantitative electrochemical diagnostic test strips.
The project has received funding from the European Union´s Horizon 2020 research and innovation program. R-Biopharm provides the knowledge and technology for lateral flow tests to IMPETUS. With the expertise of our specialists and our materials we contribute to the development of the biochemical assay and the biosensing test card. Having a vast knowledge of the biotechnology market, R-Biopharm will also be one of the key partners for the dissemination and exploitation of the results obtained by the IMPETUS project.
Detailed information can be found on the IMPETUS website.
